ELVN · ISSUER CIK 1672619
Enliven Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Enliven Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $11.8M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 7 of 8 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$11.8MInsider selling
−$11.8MNet open-market
Oct 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 202617:53 | Oct 19, 2026 | ELVN | CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $38.48 | −6,018 | 38,000 | -14% | −$232K | ||
| Oct 21, 202617:53 | Oct 19, 2026 | ELVN | CHIEF FINANCIAL OFFICER | M · Exercise10b5-1 | $14.85 | +6,018 | 44,018 | +16% | $89K | ||
| Oct 21, 202617:51 | Oct 19, 2026 | ELVN | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $38.47 | −5,000 | 25,000 | -17% | −$192K | ||
| Oct 21, 202617:51 | Oct 19, 2026 | ELVN | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $2.48 | +5,000 | 30,000 | +20% | $12K | ||
| Oct 5, 202616:57 | Oct 1, 2026 | ELVN | Director | S · Sell | $46.67 | −13,000 | 0 | -100% | −$607K | ||
| Oct 5, 202616:57 | Oct 1, 2026 | ELVN | Director | M · Exercise | $15.47 | +13,000 | 13,000 | New | $201K | ||
| Sep 21, 202617:23 | Sep 17, 2026 | ELVN | CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $50.35 | −6,018 | 38,000 | -14% | −$303K | ||
| Sep 21, 202617:23 | Sep 17, 2026 | ELVN | CHIEF FINANCIAL OFFICER | M · Exercise10b5-1 | $14.85 | +3,982 | 44,018 | +10% | $59K | ||
| Sep 21, 202617:22 | Sep 17, 2026 | ELVN | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $50.35 | −5,000 | 25,000 | -17% | −$252K | ||
| Sep 21, 202617:22 | Sep 17, 2026 | ELVN | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $2.48 | +5,000 | 30,000 | +20% | $12K | ||
| Aug 19, 202616:17 | Aug 17, 2026 | ELVN | CHIEF FINANCIAL OFFICER | S · Sell10b5-1 | $58.58 | −6,018 | 40,036 | -13% | −$353K | ||
| Aug 19, 202616:16 | Aug 17, 2026 | ELVN | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $58.59 | −5,000 | 25,000 | -17% | −$293K | ||
| Aug 19, 202616:16 | Aug 17, 2026 | ELVN | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $2.48 | +5,000 | 30,000 | +20% | $12K | ||
| Aug 6, 202620:18 | Aug 4, 2026 | ELVN | Director | S · Sell10b5-1 | $60.21 | −158,795 | 0 | -100% | −$9.6M | ||
| Aug 6, 202620:18 | Aug 4, 2026 | ELVN | Director | M · Exercise10b5-1 | $10.84 | +158,795 | 158,795 | New | $1.7M |